Tuesday, September 24, 2019
- 1:45pm-3:15pm
-
Evaluation of Clinical Peculiarities of Violations of Vertical Vision in Patients with Parkinson’s Disease
Parkinsonisms and Parkinson-Plus · Agora 3 West, Level 3
- 1:45pm-3:15pm
-
Evaluation of Constipation in Patients with Parkinson’s Disease and its Correction
Parkinsonisms and Parkinson-Plus · Agora 3 West, Level 3
- 1:45pm-3:15pm
-
Evaluation of dose rate of photobiomodulation (light) therapy in patients with Parkinson’s Disease: Double blind placebo-controlled pilot trial. Is there a dose frequency per week that influences quality of life, mobility and cognition?
Parkinsonisms and Parkinson-Plus · Agora 3 West, Level 3
- 1:45pm-3:15pm
-
Examining level of hemoglobin in patients with parkinson’s disease and the role of hemoglobin level in the disease course
Parkinsonisms and Parkinson-Plus · Agora 3 West, Level 3
- 1:45pm-3:15pm
-
Examining supplementary motor area-primary motor cortex connectivity in tremor-dominant Parkinson’s disease using a novel transcranial magnetic stimulation protocol to inform clinical practice
Neurophysiology · Les Muses Terrace, Level 3
- 1:45pm-3:15pm
-
Exercise and physical activity for people with Progressive Supranuclear Palsy
Parkinsonisms and Parkinson-Plus · Agora 3 West, Level 3
- 1:45pm-3:15pm
-
Exosomes from patients with Parkinson’s disease are pathological in mice
Parkinsonisms and Parkinson-Plus · Agora 3 West, Level 3
- 1:45pm-3:15pm
-
Exploratory Analysis of Electrocortical Signal Complexity in Patients with Progressive Supranuclear Palsy and Corticobasal Degeneration
Parkinsonisms and Parkinson-Plus · Agora 3 West, Level 3
- 1:45pm-3:15pm
-
Exploring the cognitive workload during a visual search task in Parkinson’s disease
Neurophysiology · Les Muses Terrace, Level 3
- 1:45pm-3:15pm
-
Expression analysis of candidate genes in a cell model of affected and unaffected THAP1 mutation carriers and controls
Dystonia · Les Muses Terrace, Level 3
- «Previous Page
- 1
- …
- 26
- 27
- 28
- 29
- 30
- …
- 69
- Next Page»